Company Filing History:
Years Active: 2005
Title: Françoise Stiernet: Innovator in Neurokinin Antagonists
Introduction
Françoise Stiernet is a notable inventor based in Sautin, Belgium. He has made significant contributions to the field of pharmacology, particularly in the development of neurokinin antagonists. His work has implications for various therapeutic applications, showcasing his innovative spirit and dedication to advancing medical science.
Latest Patents
Françoise Stiernet holds 1 patent for his invention titled "α-arylethylpiperazine derivatives as neurokinin antagonists." This patent relates to new α-arylethylpiperazine compounds that have potential uses in treating conditions influenced by neurokinin signaling.
Career Highlights
Stiernet's career is marked by his association with UCB S.A., a global biopharmaceutical company. His role at UCB has allowed him to work on cutting-edge research and development projects, contributing to the advancement of innovative therapies.
Collaborations
Throughout his career, Françoise Stiernet has collaborated with esteemed colleagues, including Christophe Genicot and Marie-Agnes Lassoie. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Françoise Stiernet's contributions to the field of neurokinin antagonists exemplify his commitment to innovation in pharmacology. His work continues to influence the development of new therapeutic options, highlighting the importance of research and collaboration in advancing medical science.